Joel M. Kremer, MD - Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis




PeerView Rheumatology CME/CNE/CPE Audio Podcast show

Summary: In this activity, experts in rheumatology discuss the latest data on treatment of RA, including the emerging evidence supporting early use of traditional and biologic antirheumatic drugs in undifferentiated arthritis and early stage RA, as well as up-to-date findings regarding the efficacy and safety of T- and B-cell-targeted biologics in RA.